Arcus Biosciences, Inc. (RCUS)
18.19
-0.42
(-2.26%)
USD |
NYSE |
Oct 30, 16:00
18.18
-0.02
(-0.08%)
After-Hours: 20:00
Arcus Biosciences Market Cap : 2.310B for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 2.310B |
| October 29, 2026 | 2.363B |
| October 28, 2026 | 2.336B |
| October 27, 2026 | 2.304B |
| October 26, 2026 | 2.256B |
| October 23, 2026 | 2.355B |
| October 22, 2026 | 2.459B |
| October 21, 2026 | 2.426B |
| October 20, 2026 | 3.016B |
| October 19, 2026 | 2.812B |
| October 16, 2026 | 2.809B |
| October 15, 2026 | 2.898B |
| October 14, 2026 | 2.861B |
| October 13, 2026 | 2.859B |
| October 12, 2026 | 3.091B |
| October 09, 2026 | 3.100B |
| October 08, 2026 | 3.026B |
| October 07, 2026 | 3.114B |
| October 06, 2026 | 3.084B |
| October 05, 2026 | 3.142B |
| October 02, 2026 | 3.104B |
| October 01, 2026 | 3.204B |
| September 30, 2026 | 3.280B |
| September 29, 2026 | 3.258B |
| September 28, 2026 | 3.176B |
| Date | Value |
|---|---|
| September 25, 2026 | 3.171B |
| September 24, 2026 | 3.183B |
| September 23, 2026 | 3.352B |
| September 22, 2026 | 3.412B |
| September 21, 2026 | 3.296B |
| September 18, 2026 | 3.205B |
| September 17, 2026 | 3.244B |
| September 16, 2026 | 3.131B |
| September 15, 2026 | 3.089B |
| September 14, 2026 | 3.057B |
| September 11, 2026 | 3.123B |
| September 10, 2026 | 3.321B |
| September 09, 2026 | 3.618B |
| September 08, 2026 | 3.691B |
| September 04, 2026 | 3.767B |
| September 03, 2026 | 3.827B |
| September 02, 2026 | 3.791B |
| September 01, 2026 | 3.773B |
| August 31, 2026 | 3.719B |
| August 28, 2026 | 3.710B |
| August 27, 2026 | 3.885B |
| August 26, 2026 | 3.907B |
| August 25, 2026 | 4.009B |
| August 24, 2026 | 3.825B |
| August 21, 2026 | 3.853B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 14.93B |
| AVITA Medical, Inc. | 484.00M |
| Iovance Biotherapeutics, Inc. | 3.841B |
| Editas Medicine, Inc. | 409.93M |
| Recursion Pharmaceuticals, Inc. | 2.153B |
Market Cap Related Metrics
| PS Ratio | 18.52 |
| PEG Ratio | -0.2011 |
| Price to Book Value | 4.979 |
| Price | 18.19 |
| Earnings Yield | -21.46% |
| PEGY Ratio | -0.2011 |